MedPath

Investigating the effect of a weight loss intervention on kidney disease progression: a randomised controlled feasibility study

Not Applicable
Recruiting
Conditions
Obesity
Diet and Nutrition - Obesity
Kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12622000069752
Lead Sponsor
Queensland University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Participants will be considered eligible when they meet the following inclusion criteria:
1.Adults aged 18 to 75 years, and able to consent in English, and
2.BMI greater than or equal to 30 kg/m2 and
3.eGFR greater than or equal to 30ml/min/1.73m2 (CKD-EPI eGFR) and
4.Persistent albuminuria with urinary albumin to creatinine ratio (uACR greater than or equal to 3 mg/mmol)

Exclusion Criteria

This study will exclude participants that do not satisfy the above inclusion criteria, or:
1.Previous or planned bariatric surgery within the next 12 months
2.Intentional weight loss > 5 % within the previous six months
3.Pregnancy or breastfeeding
4.Kidney transplant recipient
5.Unable to access smartphone, tablet or computer device
6.Significant psychiatric or psychological disorder including presence of an eating disorder or purging behaviour
7.Have an allergy or dietary intolerance, or condition whereby a formulated meal replacement or commercially prepared meal would be unsafe

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath